Corcept Therapeutics Inc CORT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:39 PM EDT
26.05quote price arrow up+0.65 (+2.56%)
Volume
479,523
52 week range
20.84 - 34.28
Loading...
  • Open25.49
  • Day High26.40
  • Day Low25.35
  • Prev Close25.40
  • 52 Week High34.28
  • 52 Week High Date09/14/23
  • 52 Week Low20.84
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap2.712B
  • Shares Out104.11M
  • 10 Day Average Volume1.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change-20.01

KEY STATS

  • Open25.49
  • Day High26.40
  • Day Low25.35
  • Prev Close25.40
  • 52 Week High34.28
  • 52 Week High Date09/14/23
  • 52 Week Low20.84
  • 52 Week Low Date04/22/24
  • Market Cap2.712B
  • Shares Out104.11M
  • 10 Day Average Volume1.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change-20.01

RATIOS/PROFITABILITY

  • EPS (TTM)1.07
  • P/E (TTM)24.36
  • Fwd P/E (NTM)27.36
  • EBITDA (TTM)122.919M
  • ROE (TTM)21.91%
  • Revenue (TTM)523.529M
  • Gross Margin (TTM)98.54%
  • Net Margin (TTM)22.54%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corcept Therapeutics Inc

 

Profile

MORE
Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients...
James Wilson
Independent Chairman of the Board
Joseph Belanoff M.D.
President, Chief Executive Officer, Co-Founder, Director
Atabak Mokari
Chief Financial Officer, Treasurer
Joseph Lyon
Chief Accounting Officer
Address
149 Commonwealth Dr
Menlo Park, CA
94025
United States

Top Peers

SYMBOLLASTCHG%CHG
AMPH
Amphastar Pharmaceuticals Inc
42.70+0.49+1.16%
HRMY
Harmony Biosciences Holdings Inc
31.55-0.14-0.46%
SUPN
Supernus Pharmaceuticals Inc
29.56-1.74-5.56%
ANIP
ANI Pharmaceuticals Inc
66.11+0.49+0.75%
COLL
Collegium Pharmaceutical Inc
38.12+0.06+0.16%